Similar articles

• [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].

  Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L. Pekhlivanov B, et al. Akush Ginekol (Sofiia). 2005;44 Suppl 2:25-7. Akush Ginekol (Sofiia). 2005. PMID: 16028400 Bulgarian.
• [Item 87--Mucocutaneous bacterial and fungal infections: Candida albicans].

  CEDEF. CEDEF. Ann Dermatol Venereol. 2012 Oct;139(11 Suppl):A40-6. doi: 10.1016/j.annder.2012.01.003. Epub 2012 Feb 24. Ann Dermatol Venereol. 2012. PMID: 23176860 French. No abstract available.
• Vulvovaginal candidiasis: topical vs. oral therapy.

  Tobin MJ. Tobin MJ. Am Fam Physician. 1995 May 15;51(7):1715-20, 1723-4. Am Fam Physician. 1995. PMID: 7754931
• [Problems of vaginal candidiasis. III. The trends in current antimycotic therapy].

  Zlatkov V, Kantardzhiev T. Zlatkov V, et al. Akush Ginekol (Sofiia). 1990;29(6):54-8. Akush Ginekol (Sofiia). 1990. PMID: 2100954 Review. Bulgarian. No abstract available.
• [Recurrent vulvovaginal mycoses].

  Salvat J, Romand P, Vincent-Genod A, Younes B, Guilbert M. Salvat J, et al. Rev Fr Gynecol Obstet. 1995 Nov;90(11):494-501. Rev Fr Gynecol Obstet. 1995. PMID: 8638082 Review. French.